Last December, the company raised its quarterly payout for the 16th consecutive year. The dividend yield investors could ...

Markets today face key jobs data, fresh U.S. tariffs, and earnings from Wendy’s, AMC Networks, and other midcaps ahead of the ...

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...

PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...

In a report released today, Steve Scala from TD Cowen maintained a Hold rating on Pfizer, with a price target of $30.00. The company’s shares closed yesterday at $23.53. Take advantage of TipRanks ...

XAU/USD consolidates above the 50-day MA, as softer U.S. data boosts rate cut odds. Gold price future hinges on inflation and ...

The issuer is solely responsible for the content of this announcement.